Advancing Kidney Health Through Innovation
Pioneering Citrate-Based Solutions for Metabolic Balance and Patient Well-Being
About Us
Prosalix is a Swiss pharmaceutical startup headquartered in Basel, Switzerland.The company is developing Pro24c, a medicinal product to treat acid-base imbalances and to reduce associated long-term risks. Compared to current treatment opportunities Pro24c will significantly improve the medium and long-term quality of life for patients
Why Choose Prosalix?
Cutting-Edge Research & Development
We are committed to pioneering citrate-based therapies, backed by extensive clinical research to improve kidney health and metabolic balance.
Proven Efficacy & Patient Benefits
Our flagship product, Pro24c, is designed for optimal solubility, easy dosing, and improved patient compliance, making treatment more effective and convenient.
Trusted by Experts & Backed by Science
Developed by leading researchers and pharmaceutical specialists, our solutions are clinically tested and trusted by healthcare.
Commitment to a Healthier Future
At Prosalix, we are more than just a pharmaceutical company—we are dedicated to transforming lives through innovative, patient-first solutions for kidney health.
Meet the team
cONTSCT US
Bruno Meyer
CEO
Sebastian Wowra
Member of the Board
- sebastian.wowra@prosalix.com
- +41 79 239 34 29